John A. Bencich
Net Worth

Last updated:

What is John A. Bencich net worth?

The estimated net worth of Mr. John A. Bencich is at least $6,237,617 as of 19 Apr 2024. He owns shares worth $27,000 as insider, has earned $5,417 from insider trading and has received compensation worth at least $6,205,200 in Achieve Life Sciences, Inc..

What is the salary of John A. Bencich?

Mr. John A. Bencich salary is $620,520 per year as Chief Executive Officer & Director in Achieve Life Sciences, Inc..

How old is John A. Bencich?

Mr. John A. Bencich is 48 years old, born in 1977.

What stocks does John A. Bencich currently own?

As insider, Mr. John A. Bencich owns shares in one company:

Company Title Shares Price per share Total value
Achieve Life Sciences, Inc. (ACHV) Chief Executive Officer & Director 10,000 $2.7 $27,000

What does Achieve Life Sciences, Inc. do?

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

ACHV logo
ACHV
Achieve Life Sciences, Inc.
$2.7

John A. Bencich insider trading

Achieve Life Sciences, Inc.

Mr. John A. Bencich has made 3 insider trades between 2015-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 25,000 units of ACHV stock on 21 Apr 2023. As of 19 Apr 2024 he still owns at least 10,000 units of ACHV stock.

Transaction Date Security Shares Price per share Total value Source
Option
Performance Restricted Stock Unit (PRSU) 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Purchase
Common Stock Warrants (right to buy) 10,000 $4.91 $49,060
Purchase
Common Stock 10,000 $4.59 $45,850
Purchase
Common Stock 5,000 $5.5 $27,500
Option
Common Stock 7,500 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 7,500 N/A N/A
Option
Performance Restricted Stock Unit (PRSU) 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Purchase
Common Stock 22,000 N/A N/A
Purchase
Common Stock Warrants (right to buy) 11,000 $4.5 $49,500
Option
Performance Restricted Stock Unit (PRSU) 7,500 N/A N/A
Option
Common Stock 7,500 N/A N/A
Option
Common Stock 68 N/A N/A
Option
Restricted Stock Unit (RSU) 68 N/A N/A
Purchase
Common Stock 6,000 N/A N/A
Option
Restricted Stock Unit (RSU) 69 N/A N/A
Option
Common Stock 69 N/A N/A
Option
Restricted Stock Unit (RSU) 1,370 N/A N/A
Option
Common Stock 1,370 N/A N/A
Option
Restricted Stock Unit (RSU) 28 N/A N/A
Option
Common Stock 28 N/A N/A
Option
Common Stock 1,443 N/A N/A
Option
Restricted Stock Unit (RSU) 1,443 N/A N/A
Option
Restricted Stock Unit (RSU) 1,443 N/A N/A
Option
Common Stock 454 N/A N/A
Option
Restricted Stock Unit (RSU) 454 N/A N/A
Option
Common Stock 3,125 N/A N/A
Option
Restricted Stock Unit (RSU) 3,125 N/A N/A
Option
Restricted Stock Unit (RSU) 5,000 N/A N/A
Sale
Common Stock 1,380 $0.57 $787
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 834 $0.83 $692
Option
Common Stock 3,125 $0.85 $2,656
Option
Restricted Stock Unit (RSU) 3,125 $0.85 $2,656
Sale
Common Stock 1,427 $2.76 $3,939
Option
Common Stock 5,000 N/A N/A
Option
Restricted Stock Unit (RSU) 5,000 N/A N/A

Achieve Life Sciences key executives

Achieve Life Sciences, Inc. executives and other stock owners filed with the SEC: